StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/17/2013 -- StockRunway.com issues special report on - Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Select Comfort Corp (NASDAQ:SCSS), VIVUS, Inc (NASDAQ:VVUS), Hanwha Solarone Co Ltd (NASDAQ:HSOL)
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) opened the session at $10.50, trading in a range of $10.30 - $10.63, and closed at $10.40. The stock showed a negative performance of -0.76% in the last trading session. Himax Technologies, Inc. operates as an IC design house with LCD manufacturing capability. The Company focuses on display IC products for display device and offers LCD technical consulting to customers to provide them with value-added technical support and integrated solutions.
Will HIMX Get Buyers Even After The Recent Rally? Find Out Here
Select Comfort Corp (NASDAQ:SCSS) traded 5.59 million shares in the last business day while the average volume of the stock remained 1.21 million shares. The stock showed a negative movement of -1.98% to end at $24.20. The 52 week range of the stock remained $16.62 - $32.84. Select Comfort Corporation (Select Comfort) is a bed manufacturer and retailer. The Company is a manufacturer, marketer, retailer and servicer of the Sleep Number bed, which allows individuals to adjust the firmness and support on each side at the touch of a button. The Company offers Sleep Number beds in three series, which includes Classic Series,
Has SCSS Found The Bottom And Ready To Gain Momentum? Find Out Here
VIVUS, Inc (NASDAQ:VVUS) reported 4.02 million shares were exchanged during the last trade, while the average volume is about 3.32million shares. The stock dropped -3.79% and finished the day at $9.68. The beta of the stock is recorded at 1.33. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese),
Why Should Investors Buy VVUS After the Recent Fall? Just Go Here and Find Out
Hanwha Solarone Co Ltd (NASDAQ:HSOL) the stock decreased -3.04% and finished the session at $5.26. Traded with volume of 3.82 million shares in the prior session and the average volume of the stock remained 2.85 million shares. Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China. The Company manufactures a range of silicon ingots, silicon wafers, Photovoltaic (PV) cells and PV modules using advanced manufacturing process technologies that have helped the Company to increase its operational efficiency.
Will HSOL Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)